Antiarrhythmic drugs in advanced organic heart disease
Goedel-Meinen, L.; Schmidt, G.; Jahns, G.; Klein, G.; Wirtzfeld, A.; Baedeker, W.; Blömer, H.
British Journal of Clinical Practice. Suppl 44: 28-30
1986
ISSN/ISBN: 0262-8767 PMID: 3089257 Document Number: 286183
Document emailed within 1 workday
Related Documents
Goldberg, P.B.; Stoner, S.A.; Roberts, J. 1978: Influence of age on activity of antiarrhythmic drugs in rat heart Advances in Experimental Medicine and Biology 97: 309-313Nawada, T.; Tanaka, Y.; Hirai, S.; Hisatome, I.; Hasegawa, J.; Kotake, H.; Mashiba, H. 1994: Evaluation of negative inotropic and antiarrhythmic effects of class 1 antiarrhythmic drugs International Journal of Clinical Pharmacology and Therapeutics 32(7): 347-355
Ernest, K. 1975: Pharmacology of new ethylenediamine derivatives (ROM-126, ROM-131, MK-142) with antiarrhythmic action. Part II. Antiarrhythmic properties, the influence on heart and some hemodynamic parameters Polish Journal of Pharmacology and Pharmacy 27(4): 381-398
Epstein, L.M.; Scheinman, M.M. 1990: Should asymptomatic patients with coronary artery disease and nonsustained ventricular tachycardia be treated with antiarrhythmic drugs? Cardiovascular Clinics 21(1): 79
Vránová, Z.; Janota, M.; Málek, P.; Vrána, M. 1976: Antiarrhythmic effect of Mercurascan in patients after surgical treatment of ischaemic heart disease Cor et Vasa 18(1): 77-79
Vasil'ev, A.P.; Strel'tsova, N.N.; Gorbunova, T.Iu.; Mal'tseva, I.A.; Zykova, E.L. 2001: Antioxidant and antiarrhythmic activity of carvedilol in patients with ischemic heart disease. Comparison with anaprilin Terapevticheskii Arkhiv 73(10): 65-67
Usuda, K.; Ikeda, T. 1991: Drug induced arrhythmias (digitalis, antiarrhythmic drugs and other drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 49(11): 2666-2671
Cerimović, S.; Lipa, I.; Gerc, V.; Rustembegović, F. 1974: Auricular fibrillation without evidence of organic heart disease Medicinski Arhiv 28(6): 579-583
Horgan, J.H.; Teo, K.K.; Harte, M. 1982: Modern drugs treatment--No. 11. Antiarrhythmic drugs Irish Medical Journal 75(11): 426-427; 429-432
Agnir, O.I.; Chapman, G.A. 1971: Atrial flutter with 1:1 A-V conduction in a patient with no apparent organic heart disease West Virginia Medical Journal 68(4): 93-98
Gifford, D.; Mirvis, D.M. 1984: Medical grand rounds. Cardiac arrhythmias without organic heart disease Journal of the Tennessee Medical Association 77(8): 465-467; 469
Follath, F. 1999: New cardiovascular drugs: expanded therapeutic possibilities in coronary heart disease and in heart failure Praxis 88(18): 809-813
Hansz, J.; Prazmowska-Owczarek, B.; Nowicka, G. 1979: Granulocyte adherence in advanced Hodgkin's disease and its dependence on antiproliferative drugs used Acta Haematologica Polonica 10(1): 7-12
Ignat'ev, M.V. 1975: Some new antiarrhythmic drugs Voenno-Meditsinskii Zhurnal 1: 73-74
Coumel, P.; Thomas, O. 1997: Antiarrhythmic drugs: how to use and to evaluate them Le Journal Medical Libanais. Lebanese Medical Journal 45(4): 221-223
Kock-Weser, J. 1975: Pharmacokinetics of antiarrhythmic drugs Cardiovascular Clinics 7(2): 191-202
Hoffman, B.F. 1997: Arrhythmias and antiarrhythmic drugs Mount Sinai Journal of Medicine new York 64(2): 136-141
Mehta, D.; Saxena, A. 1990: Safety of use of antiarrhythmic drugs Indian Heart Journal 42(6): 445-450
Harrison, D.C.; Irwin, W.G. 1981: New concepts for antiarrhythmic drugs in the 1980's Archives des Maladies du Coeur et des Vaisseaux 74(Special Issue): 73-77
Reiffel, J.A. 2001: Issues in the use of generic antiarrhythmic drugs Current Opinion in Cardiology 16(1): 23-29